Several studies have demonstrated that repeated PSA testing prior to prostate biopsy, particularly when a PSA reduction of 20% or more is observed, is associated with a lower likelihood of prostate cancer, especially high-grade disease [8]. This evidence concerns the gene KLK3 and prostate cancer.